Last month, a federal court in Maine halted the US Department of Health and Human Services (HHS) Health Resources and Services Administration’s (HRSA) 340B Rebate Model Pilot Program in its tracks — a ...

In our January 14 blog, we explained that Chief Judge Lance Walker of the U.S. District Court for the District of Maine had entered a nationwide preliminary injunction in American Hospital Association ...

Jeff Davis, a partner in the Washington, D.C., law office of Bass, Berry & Sims, advises healthcare organizations on Medicare and Medicaid billing and reimbursement issues, with a special focus on the ...

Add Yahoo as a preferred source to see more of our stories on Google. A lawyer faces sanctions for citing fake cases created by a generative AI tool. UPDATE: Jan. 8, 2025: The First Circuit Court of ...

BANGOR, Maine — The Trump administration is temporarily barred from launching its 340B Rebate Model Pilot Program on Jan. 1, 2026, a federal judge ruled. The program would change the upfront drug ...

Providers are urging the government to abandon any plans to implement after-the-fact rebates in the 340B drug discount program, arguing it would impose undue costs on hospitals and clinics and ...

Hospitals push CMS ditch 340B rebate model to require upfront Medicare drug prices, easing administrative burdens on rural and safety-net facilities.

A federal court in Maine has ordered a temporary pause on a new rebate model within the 340B Drug Pricing Program that has left hospitals worried about billing and claims under the new rules. The U.S.

The Health Resources and Services Administration (HRSA) announced that it is moving forward with a revised 340B rebate pilot that would allow qualifying drug manufacturers to provide post-purchase ...

Another legislative vehicle fine-tuning the contentious 340B drug discount program has been introduced by a bipartisan group of senators, this time with language directing the administration not to ...

The 340B rebate pilot model set to begin in January 2026 starkly presents the key tradeoff between program integrity and support for safety net providers and poses an important question: can the 340B ...

The American Hospital Association is urging the Federal Trade Commission and the Department of Justice's Antitrust Division to examine new 304B rebate models being implemented by drug companies, ...